A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer
研究单位：[1]Jiangsu HengRui Medicine Co., Ltd.[2]Anhui Provincial Cancer Hospital Hefei, Anhui, China, 230000[3]Anhui Provincial Hospital Hefei, Anhui, China, 230000[4]The First Affiliated Hospital Of Anhui Medical University Hefei, Anhui, China, 230000[5]Beijing Cancer Hospital Beijing, Beijing, China, 100000[6]Beijing Chest Hospital,Capital Medical University Beijing, Beijing, China, 100000[7]Peking University Third Hospital Beijing, Beijing, China, 100000[8]ChongQing University Cancer Hospital Chongqing, Chongqing, China, 400000[9]Fujian Medical University Union Hospital Fuzhou, Fujian, China, 350000[10]Fujian Provincial Cancer Hospital Fuzhou, Fujian, China, 350000[11]The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China, 361000[12]The Second Affiliated Hospital of Xiamen Medical College Xiamen, Fujian, China, 361000[13]The People's Hospital of Gaozhou Gaozhou, Guangdong, China, 525200[14]Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou, Guangdong, China, 510000[15]The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China, 510000[16]The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China, 510000[17]Meizhou People's Hospital (Huangtang Hospital) Meizhou, Guangdong, China, 514000[18]Shantou Central Hospital Shantou, Guangdong, China, 515000[19]Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China, 524000[20]Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China, 541000[21]Guangxi Medical University Affiliated Tumor Hospital Nanning, Guangxi, China, 530000[22]The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China, 530000[23]Affiliated Hospital of Zunyi Medical University Zunyi, Guizhou, China, 563000[24]Hainan General Hospital Haikou, Hainan, China, 570100[25]The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050000河北医科大学第四医院[26]North China University Of Science And Technology Affiliated Hospital Tangshan, Hebei, China, 063000[27]Xingtai People's Hospital Xingtai, Hebei, China, 054000[28]Haerbin Medical University Cancer Hospital Ha'erbin, Heilongjiang, China, 150000[29]Anyang Cancer Hospital Anyang, Henan, China, 455000[30]The First Affiliated Hosptial of Henan University of Science & Technology Luoyang, Henan, China, 471000[31]Henan Cancer Hospital Zhengzhou, Henan, China, 450000[32]The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China, 450000[33]Shiyan Taihe Hospital Shiyan, Hubei, China, 442000[34]Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China, 430000[35]Xiangyang Central Hospital Xiangyang, Hubei, China, 441000[36]Army Medical Center of PLA Changsha, Hunan, China, 410000[37]Hunan Cancer Hospital-Thoracic Medicine Department I Changsha, Hunan, China, 410000[38]Hunan Cancer Hospital-Thoracic Medicine Department Ⅱ Changsha, Hunan, China, 410000[39]Xiangya Hospital Central South University Changsha, Hunan, China, 410000[40]Shaoyang Central Hospital Shaoyang, Hunan, China, 422000[41]Zhuzhou Central Hospital Zhuzhou, Hunan, China, 412000[42]Affiliated Drum Tower Hospital, Medical School of Nanjing University Nanjing, Jiangsu, China, 210000[43]Zhongda Hospital Southeast University Nanjing, Jiangsu, China, 210000[44]Nantong Tumor Hospital Nantong, Jiangsu, China, 226000[45]Affiliated Hospital of JiangNan University Wuxi, Jiangsu, China, 214000[46]The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China, 221000[47]Northern Jiangsu People's Hospital Yangzhou, Jiangsu, China, 225000[48]First Affiliated Hospital of Gannan Medical University Ganzhou, Jiangxi, China, 341000[49]The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China, 330000[50]The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China, 330000[51]Liaoning Cancer Hospital Shenyang, Liaoning, China, 110000[52]Shengjing Hospital Affiliated to China Medical University Shenyang, Liaoning, China, 110000[53]The First Hospital of China Medical University Shenyang, Liaoning, China, 110000[54]Chifeng City Hospital Chifeng, Neimenggu, China, 024000[55]The Affiliated Hospital of Inner Mongolia Medical University Hohhot, Neimenggu, China, 010000[56]Qilu Hospital of Shandong University Jinan, Shandong, China, 250000[57]Shandong Cancer Hospital&Institute Jinan, Shandong, China, 250000[58]The Affiliated of Qingdao University Qingdao, Shandong, China, 266000[59]LinYi Cancer Hospital Linyi, Shangdong, China, 276000[60]Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200000[61]Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200000[62]Shanghai Chest Hospital Shanghai, Shanghai, China, 200000[63]Shanghai Pulmonary Hospital Shanghai, Shanghai, China, 200000[64]Baoji Central Hospital Baoji, Shanxi, China, 721000[65]Changzhi People's Hospital Changzhi, Shanxi, China, 046000[66]General Hospital of TISCO Taiyuan, Shanxi, China, 030000[67]Shanxi Bethune Hospital Taiyuan, Shanxi, China, 030000[68]Shanxi Provincial Cancer Hospital Taiyuan, Shanxi, China, 030000[69]The Second Affiliated Hospital of Air Force Military University Tangdu Hospital Xi'an, Shanxi, China, 710000[70]Sichuan Cancer Hospital Chengdu, Sichuan, China, 610000[71]The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan, China, 646000[72]Mianyang Central Hospital Mianyang, Sichuan, China, 621000[73]Yibin Second People's Hospital Yibin, Sichuan, China, 644000[74]Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin, China, 300000[75]Yunnan Cancer Hospital Kunming, Yunnan, China, 650000[76]Hangzhou Cancer Hospital Hangzhou, Zhejiang, China, 310000[77]The First Affiliated Hospital, College of Medicine, Zhejiang University of Medicine Hangzhou, Zhejiang, China, 310000[78]The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China, 310000[79]ZheJiang Cancer Hospital Hangzhou, Zhejiang, China, 310000[80]Anhui Chest Hospital Hefei, Anhui, China, 230000
研究目的：
The study is being conducted to evaluate the efficacy, and safety of camrelizumab combined with famitinib malate vs. pembrolizumab in treatment naïve subjects with programmed death-ligand 1(PD-L1)-positive recurrent or metastatic non-small cell lung cancer (NSCLC).
